Puberty blockers for people aged under 18 with gender dysphoria will be indefinitely banned by the UK Government.

In the letter, 77 Nobel Prize winners argue that appointing RFK as Secretary of HHS would put the US public’s health in jeopardy.

China’s NMPA has granted approval to Santhera Pharmaceuticals’ AGAMREE, used in treating DMD in individuals aged four years and above.

The push to replace Albert Bourla as Pfizer’s CEO drew attention from the pharma industry but was soon derailed by several events.

Meitheal Pharmaceuticals has gained exclusive US commercial rights for XENLETA for treating CABP in the adult population.

Emerging infectious diseases necessitate rapid production of raw materials for vaccines. Strengthening domestic production and a resilient supply chain are key; advanced manufacturing facilities, like ...

Sanofi has announced that its two combination vaccine candidates have received fast track status from the US FDA.

In a new webinar, industry experts explain how innovative technology is reshaping healthcare delivery, enabling proactive interventions that improve patient outcomes, relieve NHS pressures, and pave ...